ANTICANCER COMBINATION THERAPY
- 专利权人:
- Boehringer Ingelheim International GmbH
- 发明人:
- Dorothea RUDOLPH,Markus RESCHKE
- 申请号：
- US16500572
- 公开号：
- US20200101079A1
- 申请日:
- 2018.04.04
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The invention describes anti-cancer therapies comprising using an MDM2 inhibitor in combination with a PD-1 antagonist and a LAG-3 antagonist, each as described herein.
- 来源网站：
- 中国工程科技知识中心
